Bristol Myers Squibb (BMY) Return on Equity Growth (1y) (2012 - 2026)

Bristol Myers Squibb (BMY) Return on Equity Growth (1y) (2012 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROE Growth (1y) (Qtr)
1	Gsk	92,316,836.42 Bn	92,316,831.46 Bn	7.76 Bn	-
2	Eli Lilly	983.57 Bn	978.29 Bn	16.22 Bn	12.00
3	Johnson & Johnson	553.56 Bn	531.50 Bn	15.96 Bn	0.00
4	AbbVie	383.35 Bn	374.00 Bn	10.78 Bn	-2.00
5	Merck	281.71 Bn	276.06 Bn	12.09 Bn	0.00
6	Amgen	182.20 Bn	170.16 Bn	5.87 Bn	0.00
7	Gilead Sciences	153.71 Bn	145.98 Bn	5.52 Bn	0.00
8	Pfizer	143.75 Bn	130.98 Bn	-1.21 Bn	0.00
9	Bristol Myers Squibb	109.71 Bn	99.25 Bn	8.07 Bn	0.00
10	Novartis Ag	108.28 Bn	107.60 Bn	-	-

Download Data